Project 2: Cellular topography and function of the breast cancer tissue microenvironment

项目2:乳腺癌组织微环境的细胞形态和功能

基本信息

  • 批准号:
    10272390
  • 负责人:
  • 金额:
    $ 26.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-14 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

Abstract/Project Summary Breast cancer (BC) metastasis is an emergent feature that occurs when the tumor’s ability to recruit metabolic resources, avoid immune activation, and disseminate to distant sites exceeds the capacity of surrounding normal tissue to prevent these processes. In line with this, work over the last decade has demonstrated the crucial role played by the tumor microenvironment (TME) in promoting or deterring BC progression. Tumor cell migration and immune recruitment have both been shown to be heavily influenced by fibroblasts and the surrounding extracellular matrix (ECM) they produce. Additionally, protein glycosylation has been shown to modulate these interactions. To understand how tumor glycosylation and ECM remodeling interact to potentiate BC metastasis, we will use spatial transcriptomics and two complementary mass spectrometry methods, MIBI-TOF and MALDI, to identify glycan-dependent, cell-cell, and cell-ECM interactions that shift the TME toward tumor permissive states. All three analyses will be performed on spatially-coregistered serial sections from the same tissue blocks. In doing so, comprehensive single-cell maps of each tissue sample constructed by MIBI-TOF can be directly superimposed with de novo proteomic and transcriptomic data. We will map and enumerate the lineage and major functional subsets of tumor and stromal cells with respect to relevant therapeutic and molecular parameters to understand how the BC TME evolves with disease progression. These features will be overlaid with de novo imaging of tissue glycans to identify potential mechanisms of immune evasion that involve tumor sialoglycans and macrophage-bound SIGLECs. The frequency and spatial enrichment of these features will be correlated with spatial transcriptomics data to identify regulatory glycosyltransferases promoting these interactions. Next, ECM-MALDI and MIBI-TOF data will be used to identify how collagen type, hydroxylation, and crosslinking shift in coordination with the collagen structure and function of neighboring cell populations. In particular, we will focus on understanding how the activity of two families of enzymes, prolyl and lysyl hydroxylases, drive structural changes in the ECM that promote BC metastasis. The clinical significance of these extracted cellular and molecular definitions of ECM remodeling will be assessed with respect to metastatic risk, stage, and IC subtype. Taken together, this work will provide an unprecedented view into how TME structure and cell-cell interactions between tumor and stroma relate to specific facets of the tumor ECM and glycome.
摘要/项目摘要 乳腺癌(BC)转移是一种紧急特征,当肿瘤的新陈代谢能力 资源,避免免疫激活,并传播到远端超过周围正常能力的地方 组织来阻止这些过程。与此相一致,过去十年的工作证明了这一关键作用 由肿瘤微环境(TME)在促进或阻止BC进展中发挥作用。肿瘤细胞迁移 和免疫募集都被证明受到成纤维细胞和周围环境的严重影响 它们产生细胞外基质(ECM)。此外,蛋白质的糖基化已被证明可以调节这些 互动。为了了解肿瘤糖基化和细胞外基质重塑如何相互作用以增强BC转移, 我们将使用空间转录和两种互补的质谱学方法,MIBI-TOF和MALDI, 确定糖依赖、细胞-细胞和细胞-ECM相互作用使TME向肿瘤允许方向转变 各州。所有这三种分析都将在来自相同组织块的空间共配准的连续切片上进行。 通过这样做,MIBI-TOF构建的每个组织样本的全面单细胞图谱可以直接 叠加了从头开始的蛋白质组和转录组数据。我们将绘制并列举世系和 肿瘤和基质细胞的主要功能亚群与相关的治疗和分子 参数以了解BC TME如何随着疾病的进展而演变。这些要素将被叠加 通过组织糖链的从头成像来确定涉及肿瘤的潜在免疫逃逸机制 唾液酸聚糖和巨噬细胞结合的SIGLECs。这些特征的频率和空间丰富程度将是 与空间转录数据相关联以识别促进这些的调节糖基转移酶 互动。接下来,ECM-MALDI和MIBI-TOF数据将被用来确定胶原类型、羟化和 与邻近细胞群的胶原蛋白结构和功能相协调的交联性变化。在……里面 特别是,我们将重点了解两个酶家族,Pro和赖氨酸的活性是如何 羟基酶,驱动ECM的结构变化,促进BC转移。这些指标的临床意义 提取的ECM重塑的细胞和分子定义将根据转移风险进行评估, 阶段,和IC亚型。综上所述,这项工作将提供一个前所未有的视角来了解TME的结构 肿瘤和间质之间的细胞间相互作用与肿瘤细胞外基质和糖蛋白的特定方面有关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert michael Angelo其他文献

Robert michael Angelo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert michael Angelo', 18)}}的其他基金

Multimodal histologic atlas of human bone marrow
人骨髓多模态组织学图谱
  • 批准号:
    10531005
  • 财政年份:
    2022
  • 资助金额:
    $ 26.33万
  • 项目类别:
Data Analysis, Integration, and Sharing Core
数据分析、整合、共享核心
  • 批准号:
    10531006
  • 财政年份:
    2022
  • 资助金额:
    $ 26.33万
  • 项目类别:
Multimodal histologic atlas of human bone marrow
人骨髓多模态组织学图谱
  • 批准号:
    10924351
  • 财政年份:
    2022
  • 资助金额:
    $ 26.33万
  • 项目类别:
Multimodal histologic atlas of human bone marrow
人骨髓多模态组织学图谱
  • 批准号:
    10673893
  • 财政年份:
    2022
  • 资助金额:
    $ 26.33万
  • 项目类别:
Project 2: Cellular topography and function of the breast cancer tissue microenvironment
项目2:乳腺癌组织微环境的细胞形态和功能
  • 批准号:
    10704687
  • 财政年份:
    2021
  • 资助金额:
    $ 26.33万
  • 项目类别:
A robust platform for multiplexed, subcellular proteomic imaging in human tissue
用于人体组织多重亚细胞蛋白质组成像的强大平台
  • 批准号:
    9894465
  • 财政年份:
    2019
  • 资助金额:
    $ 26.33万
  • 项目类别:
A robust platform for multiplexed, subcellular proteomic imaging in human tissue
用于人体组织多重亚细胞蛋白质组成像的强大平台
  • 批准号:
    10247827
  • 财政年份:
    2019
  • 资助金额:
    $ 26.33万
  • 项目类别:
MIRIAD - Multiplexed Imaging of Resilience In Alzheimers Disease
MIRIAD - 阿尔茨海默病恢复力的多重成像
  • 批准号:
    9974453
  • 财政年份:
    2017
  • 资助金额:
    $ 26.33万
  • 项目类别:
MIRIAD - Multiplexed Imaging of Resilience In Alzheimers Disease
MIRIAD - 阿尔茨海默病恢复力的多重成像
  • 批准号:
    9439172
  • 财政年份:
    2017
  • 资助金额:
    $ 26.33万
  • 项目类别:
The Phenotypic Landscape of Cognitive Decline as Revealed by Next-Generation Multiplexed Ion Beam Imaging
下一代多重离子束成像揭示认知衰退的表型景观
  • 批准号:
    9910356
  • 财政年份:
    2017
  • 资助金额:
    $ 26.33万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 26.33万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 26.33万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 26.33万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.33万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 26.33万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 26.33万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 26.33万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 26.33万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 26.33万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 26.33万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了